STOCK EXCHANGE ANNOUNCEMENT
Lars Høie has on 28 September 2016 sold 25,000,000 shares, disposed of 1,500,000 Subscription Rights and exercised his remaining 96,199,303 Subscription Rights in the rights offering in Bionor Pharma ASA (the "Company"). Following these transactions and issuance of the new shares in the Rights Offering Lars Høie holds 121,453,370 shares, equalling 8.76% of the then issued share capital.
Lars Høie further owns 15,253,370 warrants in the Company. His total holding of shares and warrants equals 9.86% based on the new share capital following registration of the new shares issued in the Rights Offering and equalling 15.88%, based on the registered share capital as of today.
Lars Høie has oversubscribed in the Rights Offering. Allocation of shares is expected on or about 4 October 2016.
This information is subject to the disclosure requirements set out in section 4-3 of the Norwegian Securities Trading Act.Bionor_SEA20160928_MandatoryNotificationOfTrade_Hoie
Last updated on: 29/09/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.